SMI-4a is a potent inhibitor of Pim1 with IC50 of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Pim1 ↓ ↑ | Pim2 ↓ ↑ | Pim3 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SMI-4a |
++
Pim1, IC50: 17 nM |
99%+ | |||||||||||||||||
SGI-1776 free base |
++
Pim1, IC50: 7 nM |
+
Pim2, IC50: 363 nM |
+
Pim3, IC50: 69 nM |
FLT3 | 99+% | ||||||||||||||
AZD-1208 |
+++
Pim1, IC50: 0.4 nM |
+++
Pim2, IC50: 5 nM |
+++
Pim3, IC50: 1.9 nM |
98% | |||||||||||||||
CX-6258 HCl |
+++
Pim1, IC50: 5 nM |
+
Pim2, IC50: 25 nM |
++
Pim3, IC50: 16 nM |
98% | |||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | Pim (provirus integration site for Moloney murine leukemia virus) family proteins are highly conserved serine/threonine kinases implicated in transcription, translation, cell cycle, survival, and drug resistance through the numerous targets. SMI-4a is a potent inhibitor of Pim1 with IC50 of 17 nM (measured by kinase activity assay), as well as shows modest potency to Pim-2. As BAD is a novel substrate of Pim-1, SMI-4a < 5 μM caused dose-dependent reduction of p-BAD in prostate and hematopoietic cells tested. Treatment with 5 μM SMI-4a for 72 h showed various degree of growth inhibition (10-40%) of PC3, DU145, LNCaP, U937, K562 and MV4;11 cells cultured in media containing 10% FBS. Because SMI-4a showed to be serum-bound, it was found that DU145 cells became considerably more sensitive under serum-free conditions. For many substrates of Pim-1 play a role in cell cycle progression, as prediction, treatment with 5 μM SMI-4a for 72 h caused a significant G1 cell cycle arrest of DU145 cells growing in 2% serum and MV4;11 cells plated in 10% serum, as well as a considerable amount of apoptosis (sub-G1 29.2%) of 22Rv1 cells cultured under serum starvation condition. The translocation of p27Kip1 to the nucleus and reduced Cdk2 activity (shown by decreased p-H1) can also observed in K562 cells cultured in RPMI containing 10% FCS after treatment with SMI-4a. SMI-4a can synergize with rapamycin to cause significant growth inhibition, as well as decreased phosphorylation level of 4E-BP1 of MV4;11 and FDCP1 (IL-3 dependent) cells[1]. Combination treatment of ABT-737 (50 mg/kg; i.p., QD) and SMI-4a (60 mg/kg, oral gavage, BID) for 16 days significantly reduce the tumor growth of LNCaP xenograft model[2]. |
作用机制 | SMI-4a can compete with respect to ATP, suggesting that it may bind within the ATP-binding pocket of the kinase.[1] |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
DLD-1 cell | Function assay | 96 h | Inhibition of growth of DLD-1 cell line after 96 hours of exposure time with the compound dissolved in DMSO, IC50=17.8 μM | 15993594 | |
HCT116 cell | Function assay | 72 h | Inhibition of growth of HCT116 cell line after 72 hours of exposure time with the compound dissolved in DMSO, IC50=48.8 μM | 15993594 | |
HEK293T cells | 0.5 μM | Function assay | 1 h | Inhibition of human recombinant Flag-Pim1 autophosphorylation expressed in HEK293T cells labeled with [32PO4] at 0.5 uM after 1hr by Western blotting | 19072652 |
HT-29 cell | Function assay | Inhibition of growth of HT-29 cell line after 72+72 hours of exposure time with the compound dissolved in DMSO, IC50=31.4 μM | 15993594 | ||
Dose | Mice: 60 mg/kg[4] (p.o.), 5 mg/kg - 40 mg/kg[5], 15 mg/kg[6] (intratumorally) | ||||||||||||
Administration | p.o., intratumorally | ||||||||||||
Pharmacokinetics |
|
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.66mL 0.73mL 0.37mL |
18.30mL 3.66mL 1.83mL |
36.60mL 7.32mL 3.66mL |
CAS号 | 438190-29-5 |
分子式 | C11H6F3NO2S |
分子量 | 273.231 |
别名 | TCS-PIM-1-4a |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(384.29 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
IP 2% DMSO+2% Tween80+40% PEG300+water 5 mg/mL clear PO 0.5% CMC-Na 43 mg/mL suspension |